-
2381
-
2382
-
2383
Liraglutide Regulates the Kidney and Liver in Diabetic Nephropathy Rats through the miR-34a/SIRT1 Pathway
Published 2021-01-01Get full text
Article -
2384
-
2385
-
2386
-
2387
AMPK: An energy sensor for non-small cell lung cancer progression and treatment
Published 2025-02-01Get full text
Article -
2388
Widely Targeted Metabolomics Analysis Reveals Key Quality-Related Metabolites in Kernels of Sweet Corn
Published 2021-01-01Get full text
Article -
2389
-
2390
Structural-Electromagnetic-Thermal Coupling Technology for Active Phased Array Antenna
Published 2023-01-01Get full text
Article -
2391
-
2392
Tear metabolomics reveals novel potential biomarkers in epithelial herpes simplex keratitis
Published 2025-01-01Get full text
Article -
2393
Genome‐wide association study of tuberculosis in the western Chinese Han and Tibetan population
Published 2023-04-01Get full text
Article -
2394
-
2395
Roles of the <i>Sec2p</i> Gene in the Growth and Pathogenicity Regulation of <i>Aspergillus fumigatus</i>
Published 2025-01-01Get full text
Article -
2396
-
2397
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Published 2023-04-01Get full text
Article -
2398
-
2399
Understanding the Behavioral Differences Between American and German Users: A Data-Driven Study
Published 2018-12-01Get full text
Article -
2400
Dynamic Complement Protein Changes in Aqueous Humor and Plasma of Patients With Retinal Vein Occlusion During Ranibizumab Treatment
Published 2025-01-01“…Tingting Guo,1,2,* Yanying Zhao,2,3,* Shengnan Liang,2,3 Jie Wang,2 Hengwei Liu,2 Yufan Zhou,2 Heping Xu,3– 5 Zhongping Chen1– 3,6 1Aier Eye Hospital, Jinan University, Guangzhou, People’s Republic of China; 2Changsha Aier Eye Hospital, Changsha, People’s Republic of China; 3Aier Academy of Ophthalmology, Central South University, Changsha, People’s Republic of China; 4Aier Institute of Optometry and Vision Science, Aier Eye Hospital Group, Changsha, People’s Republic of China; 5The Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK; 6School of Stomatology and Ophthalmology, Xianning Medical College, Xianning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhongping Chen; Heping Xu, Email chenzhongping@csu.edu.cn; heping.xu@qub.ac.ukPurpose: To assess dynamic changes of complement protein in aqueous humor (AH) and plasma of retinal vein occlusion (RVO) patients during ranibizumab treatment, and to explore the differential expression of complement proteins in branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO).Patients and Methods: This prospective, consecutive case series study collected AH and plasma samples from 27 RVO patients at baseline, 1 and 2 months after ranibizumab treatment, including 19 BRVO and 8 CRVO patients. …”
Get full text
Article